Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda

Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda

(2018) M. Chantal Umulisa et al.   BMC Womens Health

Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial

(2018) Alex K Mezei et al.   BMJ Open

Optimizing secondary prevention of cervical cancer: Recent advances and future challenges

(2017) Gina Ogilvie et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial

(2017) Darrel A. Cook et al.   JOURNAL OF CLINICAL VIROLOGY

Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings

(2017) Nicole G. Campos et al.   Cancer Medicine

A review of the clinical performance of the Aptima HPV assay

(2016) Juliane Haedicke et al.   JOURNAL OF CLINICAL VIROLOGY

Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study

(2016) Sveinung Wergeland Sørbye et al.   BMJ Open

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years

(2015) Matejka Rebolj et al.   EUROPEAN JOURNAL OF CANCER

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

(2015) Thomas Iftner et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of Human Papillomavirus Detection by Aptima HPV and cobas HPV Tests in a Population of Women Referred for Colposcopy following Detection of Atypical Squamous Cells of Undetermined Significance by Pap Cytology

(2015) Philip E. Castle et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa

(2015) Paul C. Adamson et al.   PLoS One

The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa

(2015) Anna-Lise Williamson   Journal of Clinical Medicine

Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting

(2014) Pierre-Marie Tebeu et al.   INTERNATIONAL JOURNAL OF CANCER

A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer

(2014) Jose Jeronimo et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

(2013) D. A. M. Heideman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

(2013) L. Stewart Massad et al.   OBSTETRICS AND GYNECOLOGY

High-Risk Human Papillomavirus Messenger RNA Testing in Physician- and Self-Collected Specimens for Cervical Lesion Detection in High-Risk Women, Kenya

(2013) Jie Ting et al.   SEXUALLY TRANSMITTED DISEASES

Global Burden of Human Papillomavirus and Related Diseases

(2012) David Forman et al.   VACCINE

Human Papillomavirus, Human Immunodeficiency Virus and Immunosuppression

(2012) Lynette A. Denny et al.   VACCINE

The known unknowns of HPV natural history

(2011) Patti E. Gravitt   JOURNAL OF CLINICAL INVESTIGATION

Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review

(2011) Cecily Banura et al.   Infectious Agents and Cancer

Human Papillomavirus–Based Cervical Cancer Prevention: Long-term Results of a Randomized Screening Trial

(2010) Lynette Denny et al.   JNCI-Journal of the National Cancer Institute

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

(2009) Janel Dockter et al.   JOURNAL OF CLINICAL VIROLOGY

Towards a new standard of care for patients with myeloma?

(2009) Antonio Palumbo et al.   LANCET ONCOLOGY

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Human Papillomavirus Genotypes Among High-Risk Women: A Comparison of Hybrid Capture and Linear Array Tests

(2009) Joseph Monsonego et al.   SEXUALLY TRANSMITTED DISEASES

Reducing bias through directed acyclic graphs

(2008) Ian Shrier et al.   BMC Medical Research Methodology

HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy

(2008) Hugo De Vuyst et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda

(2008) M Safaeian et al.   SEXUALLY TRANSMITTED INFECTIONS

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

(2008) Jack Cuzick et al.   VACCINE